| Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study PS Chauhan, K Chen, RK Babbra, W Feng, N Pejovic, A Nallicheri, ... PLoS medicine 18 (8), e1003732, 2021 | 52 | 2021 |
| Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study JJ Szymanski, RT Sundby, PA Jones, D Srihari, N Earland, PK Harris, ... PLoS Medicine 18 (8), e1003734, 2021 | 42 | 2021 |
| ctDNA MRD detection and personalized oncogenomic analysis in oligometastatic colorectal cancer from plasma and urine B Pellini, N Pejovic, W Feng, N Earland, PK Harris, A Usmani, ... JCO Precision Oncology 5, 378-388, 2021 | 36 | 2021 |
| Cell-Free DNA Alterations in the AR Enhancer and Locus Predict Resistance to AR-Directed Therapy in Patients With Metastatic Prostate Cancer HX Dang, PS Chauhan, H Ellis, W Feng, PK Harris, G Smith, M Qiao, ... JCO precision oncology 4, 680-713, 2020 | 21 | 2020 |
| Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients PS Chauhan, A Shiang, I Alahi, RT Sundby, W Feng, B Gungoren, ... NPJ Precision Oncology 7 (1), 6, 2023 | 19 | 2023 |
| Tracking minimal residual disease with urine tumor DNA in muscle-invasive bladder cancer after neoadjuvant chemotherapy. K Chen, PS Chauhan, RK Babbra, W Feng, N Pejovic, A Nallicheri, ... Journal of Clinical Oncology 39 (15_suppl), e16514-e16514, 2021 | 2 | 2021 |
| PACT: a pipeline for analysis of circulating tumor DNA J Webster, HX Dang, PS Chauhan, W Feng, A Shiang, PK Harris, ... Bioinformatics 39 (8), btad489, 2023 | 1 | 2023 |
| Integrative analysis of urine cell-free DNA for the detection of residual disease in localized bladder cancer patients. PS Chauhan, A Shiang, K Chen, R Babbra, W Feng, JJ Szymanski, ... Journal of Clinical Oncology 40 (6_suppl), 559-559, 2022 | 1 | 2022 |
| Correction: Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study PS Chauhan, K Chen, RK Babbra, W Feng, N Pejovic, A Nallicheri, ... PLoS Medicine 18 (12), e1003876, 2021 | 1 | 2021 |
| Urinary Tumor DNA Detection of Muscle-Invasive Bladder Cancer May be Superior to Surgical Pathologic Complete Response Status for Predicting Survival Outcomes RK Babbra, PS Chauhan, N Pejovic, W Feng, PK Harris, A Nallicheri, ... International Journal of Radiation Oncology, Biology, Physics 108 (3), e916, 2020 | 1 | 2020 |
| Urinary cell-free DNA analysis for tumor mutation detection in patients with oligometastatic colorectal cancer. B Pellini, N Pejovic, P Harris, W Feng, A Usmani, F Qaium, R Fields, ... Journal of Clinical Oncology 38 (15_suppl), e15545-e15545, 2020 | 1 | 2020 |
| Epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse prognosis in AR-altered lethal metastatic castration resistant prostate cancer PS Chauhan, I Alahi, S Sinha, R Mueller, AL Shiang, J Webster, HX Dang, ... Cancer Research 84 (6_Supplement), 983-983, 2024 | | 2024 |
| 22. Cell-free DNA genomic and epigenomic analysis to predict survival in mCRPC patients treated with AR-directed therapy P Chauhan, I Alahi, A Shiang, J Webster, H Dang, L Greiner, B Yang, ... Cancer Genetics 278, 7, 2023 | | 2023 |
| Combinatorial genomic and epigenomic cell-free DNA analysis of high-risk metastatic castration resistant prostate cancer reveals prognostic liquid biopsy signatures I Alahi, PS Chauhan, AL Shiang, J Webster, HX Dang, L Greiner, B yang, ... Cancer Research 83 (7_Supplement), 6698-6698, 2023 | | 2023 |
| Urine cell-free DNA multi-omics to detect molecular residual disease and predict survival in bladder cancer patients PS Chauhan, AL Shiang, I Alahi, RT Sundby, W Feng, B Gungoren, ... Cancer Research 83 (7_Supplement), 2219-2219, 2023 | | 2023 |
| Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in AR-altered lethal prostate cancer PS Chauhan, I Alahi, S Sinha, AL Shiang, R Mueller, J Webster, HX Dang, ... medRxiv, 2023.12. 01.23299215, 2023 | | 2023 |
| 86. Whole genome sequencing of mouse derived cell-free DNA to develop a NF1-MPNST-PDX liquid biopsy model P Jones, W Feng, X Zhang, P Harris, T Sundby, F Qaium, J Shern, ... Cancer Genetics 268, 28, 2022 | | 2022 |
| 28. Detection of small mutations, copy number alterations and structural variations from targeted cfDNA sequencing in cancer J Webster, H Dang, P Chauhan, A Shiang, W Feng, P Harris, R Pachynski, ... Cancer Genetics 268, 10, 2022 | | 2022 |
| 65. AR/enhancer alterations in metastatic castrate-resistant prostate cancer patient plasma predicts worse overall survival P Chauhan, A Shiang, H Dang, J Webster, E Ledet, R Babbra, W Feng, ... Cancer Genetics 268, 21, 2022 | | 2022 |
| Multimodal Urine Cell-Free DNA-Based Residual Disease Detection and Prognostication in Muscle-Invasive Bladder Cancer Patients A Shiang, PS Chauhan, K Chen, RT Sundby, I Alahi, RK Babbra, W Feng, ... International Journal of Radiation Oncology, Biology, Physics 114 (3), e247, 2022 | | 2022 |
